<DOC>
	<DOCNO>NCT02945722</DOCNO>
	<brief_summary>S. aureus nasal carriage well-known risk factor S. aureus infection hemodialysis ( HD ) patient . Strains carriage infection &gt; 80 % case We recently show persistent carrier S. aureus , intermittent one increase risk staphylococcal infection HD . Thanks new algorithm developped base one nasal sample determination carriage status ( persistent , intermittent non-carriers ) among patient easy . Mupirocin use HD show reduce significantly S. aureus infection however , multiple schedule decolonization propose S. aureus carrier . To date , national guideline decolonization S. aureus HD . We show 50 % HD center France propose screen decolonization S. aureus carrier . The aim study therefore evaluate impact target decolonization S. aureus persistent carrier use mupirocin nasal ointment chlorhexidine bath 5 day occurrence S. aureus infection HD patient compare absence decolonization use randomize open study methodology .</brief_summary>
	<brief_title>Study Impact Targeted Decolonization S. Aureus Persistent Carriers</brief_title>
	<detailed_description>Hemodialysis patient randomize 2 arm : one arm persistent carrier decolonize . Decolonization schedule associate use mupirocin nasal ointment 3 time day chlorhexidine bath day 5 day . Screening persistent carrier arm do every 3 month new decolonization propose patient find ( ) persistent carrier . Determination carriage status do use one nasal swab follow algorithm previously describe . Bacterial load determine quantitative S. aureus PCR ( Polymerase Chain Reaction ) : persistent carrier patient bacterial load &gt; 103 CFU/mL ( Colony Forming Unit ) . The arm HD patient decolonization perform include impersistent carrier . All infection occur enrolled patient count group</detailed_description>
	<criteria>Adults ( age â‰¥ 18 yearsold ) Patient chronic hemodialysis Patent accept participate study write consent form sign Patients peritoneal dialysis Patients active infection time inclusion Patients previously treat mupirocin chlorhexidine decolonization purpose Patients receive antimicrobial active S. aureus month inclusion Patients allergy mupirocin chlorhexidine Patients treated hemodialysis transiently ( nonterminal kidney failure ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hemodialysis</keyword>
	<keyword>S. Aureus</keyword>
	<keyword>Decolonization</keyword>
	<keyword>Persistent carriage</keyword>
</DOC>